TY - JOUR AU - M. Leveroni AU - S. Jones AU - S. Bell A1 - AB - Depression is a prevalent and increasing concern in primary care, particularly among adolescents. Evidence supports routine screening, which improves remission and symptom reduction in adults and perinatal populations. Both psychotherapy and pharmacotherapy are effective first-line treatments, with similar efficacy in reducing symptoms. Selective serotonin reuptake inhibitors (SSRIs) remain the preferred outpatient antidepressant, demonstrating superiority over placebo and comparable outcomes to other agents. Generally safe for pregnant, breastfeeding, and geriatric patients, SSRIs require thoughtful selection based on side effects, contraindications, and patient preferences. Primary care clinicians are central to providing individualized, evidence-based, and patient-centered management of depression. AD - UCI Family Health Center, 800 N. Main Street, Santa Ana, CA 92701, USA; University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA. Electronic address: mleveron@hs.uci.edu.; UCI Family Health Center, 800 N. Main Street, Santa Ana, CA 92701, USA; University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA.; University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA. AN - 42120156 BT - Prim Care C5 - Healthcare Disparities CP - 2 DA - Jun DO - 10.1016/j.pop.2026.01.002 DP - NLM ET - 20260306 IS - 2 JF - Prim Care LA - eng N2 - Depression is a prevalent and increasing concern in primary care, particularly among adolescents. Evidence supports routine screening, which improves remission and symptom reduction in adults and perinatal populations. Both psychotherapy and pharmacotherapy are effective first-line treatments, with similar efficacy in reducing symptoms. Selective serotonin reuptake inhibitors (SSRIs) remain the preferred outpatient antidepressant, demonstrating superiority over placebo and comparable outcomes to other agents. Generally safe for pregnant, breastfeeding, and geriatric patients, SSRIs require thoughtful selection based on side effects, contraindications, and patient preferences. Primary care clinicians are central to providing individualized, evidence-based, and patient-centered management of depression. PY - 2026 SN - 0095-4543 SP - 153 EP - 165+ ST - Depression Updates and Selective Serotonin Reuptake Inhibitor Management T1 - Depression Updates and Selective Serotonin Reuptake Inhibitor Management T2 - Prim Care TI - Depression Updates and Selective Serotonin Reuptake Inhibitor Management U1 - Healthcare Disparities U3 - 10.1016/j.pop.2026.01.002 VL - 53 VO - 0095-4543 Y1 - 2026 ER -